Literature DB >> 16691396

Rituximab as first line treatment for MALT lymphoma of extraocular muscles.

Leonidas Benetatos, Vasiliki Alymara, Ioannis Asproudis, Konstantinos L Bourantas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16691396     DOI： 10.1007/s00277-006-0134-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Extranodal marginal zone B-cell lymphoma involving superior rectus muscle: A clinicopathological case report.

Authors:  Junichi Fukuhara; Satoru Kase; Mika Noda; Kan Ishijima; Susumu Ishida
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

Review 2.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

Review 3.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

Review 4.  Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy.

Authors:  Salvatore Perrone; Gianna Maria D'Elia; Giorgia Annechini; Alessandro Pulsoni
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

5.  Ocular adnexal lymphoma: A single-institution retrospective study.

Authors:  César A Fernández; Roger K Henry; Carol L Shields; Jurij R Bilyk; Sara E Lally; Ralph C Eagle; Tatyana Milman
Journal:  Saudi J Ophthalmol       Date:  2022-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.